178 related articles for article (PubMed ID: 37728859)
1. Immune characteristics associated with lymph node metastasis in early-stage NSCLC.
Zhang Z; Li L; Gao Y; Xiao X; Ji L; Zhou Z; Jiang J; Liu S; An J; Deng P; Du N; Li P; Xia X; Hu C; Li M
Cell Oncol (Dordr); 2024 Apr; 47(2):447-461. PubMed ID: 37728859
[TBL] [Abstract][Full Text] [Related]
2. Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors.
Yang H; Sun B; Ma W; Fan L; Xu K; Jia Y; Xu J; Wang Z; Yao F
EBioMedicine; 2022 Oct; 84():104265. PubMed ID: 36116212
[TBL] [Abstract][Full Text] [Related]
3. TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patients.
Matsuda T; Miyauchi E; Hsu YW; Nagayama S; Kiyotani K; Zewde M; Park JH; Kato T; Harada M; Matsui S; Ueno M; Fukuda K; Suzuki N; Hazama S; Nagano H; Takeuchi H; Vigneswaran WT; Kitagawa Y; Nakamura Y
Oncoimmunology; 2019; 8(6):e1588085. PubMed ID: 31069156
[TBL] [Abstract][Full Text] [Related]
4. Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer.
Khalifa J; Thébault N; Scarlata CM; Norkowski E; Massabeau C; Brouchet L; Peries Bataille S; Casaroli C; Vaz L; Valle C; Sarot E; Saint-Laurent N; Martin E; Pages PB; Millière A; Mazières J; Cohen-Jonathan Moyal E; Lauzéral-Vizcaïno F; Ayyoub M
Front Oncol; 2023; 13():1269166. PubMed ID: 38074683
[TBL] [Abstract][Full Text] [Related]
5. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.
Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES
Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490
[TBL] [Abstract][Full Text] [Related]
6. Tumour-draining lymph nodes in head and neck cancer are characterized by accumulation of CTLA-4 and PD-1 expressing Treg cells.
Piersiala K; da Silva PFN; Lagebro V; Kolev A; Starkhammar M; Elliot A; Marklund L; Munck-Wikland E; Margolin G; Georén SK; Cardell LO
Transl Oncol; 2022 Sep; 23():101469. PubMed ID: 35714487
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
[TBL] [Abstract][Full Text] [Related]
8. Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients.
Zuckerman NS; Yu H; Simons DL; Bhattacharya N; Carcamo-Cavazos V; Yan N; Dirbas FM; Johnson DL; Schwartz EJ; Lee PP
Int J Cancer; 2013 Jun; 132(11):2537-47. PubMed ID: 23136075
[TBL] [Abstract][Full Text] [Related]
9. Intrapulmonary lymph node metastasis is common in clinically staged IA adenocarcinoma of the lung.
Zhang D; Chen X; Zhu D; Qin C; Dong J; Qiu X; Fan M; Zhuo Q; Tang X
Thorac Cancer; 2019 Feb; 10(2):123-127. PubMed ID: 30468025
[TBL] [Abstract][Full Text] [Related]
10. Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study.
Abughararah TZ; Jeong YH; Alabbood F; Chong Y; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2021 Apr; 59(4):783-790. PubMed ID: 33150427
[TBL] [Abstract][Full Text] [Related]
11. New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non-small cell lung cancer.
Zhang J; Liu L; Wang G; Huang C; Chen Y; Zhang Y; Guo C; Li S
Thorac Cancer; 2019 Dec; 10(12):2253-2258. PubMed ID: 31617316
[TBL] [Abstract][Full Text] [Related]
12. The tumor-draining lymph node as a reservoir for systemic immune surveillance.
Delclaux I; Ventre KS; Jones D; Lund AW
Trends Cancer; 2024 Jan; 10(1):28-37. PubMed ID: 37863720
[TBL] [Abstract][Full Text] [Related]
13. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
Shigemoto Y; Suga K; Matsunaga N
Ann Nucl Med; 2016 May; 30(4):287-97. PubMed ID: 27007128
[TBL] [Abstract][Full Text] [Related]
14. Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA-IIA non-small cell lung cancer, a retrospective cohort study.
Zhai W; Duan F; Zheng Y; Yan Q; Dai S; Chen T; Chen J; Wang J
World J Surg Oncol; 2020 Sep; 18(1):258. PubMed ID: 32998771
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04).
Kwon J; Eom KY; Kim YS; Park W; Chun M; Lee J; Kim YB; Yoon WS; Kim JH; Choi JH; Chang SK; Jeong BK; Lee SH; Cha J
Cancer Res Treat; 2018 Jul; 50(3):964-974. PubMed ID: 29081219
[TBL] [Abstract][Full Text] [Related]
16. Single-cell analysis reveals immune modulation and metabolic switch in tumor-draining lymph nodes.
Li YL; Chen CH; Chen JY; Lai YS; Wang SC; Jiang SS; Hung WC
Oncoimmunology; 2020 Oct; 9(1):1830513. PubMed ID: 33117603
[TBL] [Abstract][Full Text] [Related]
17. Disrupted fibroblastic reticular cells and interleukin-7 expression in tumor draining lymph nodes.
Gao J; Zhao L; Liu L; Yang Y; Guo B; Zhu B
Oncol Lett; 2017 Sep; 14(3):2954-2960. PubMed ID: 28928833
[TBL] [Abstract][Full Text] [Related]
18. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis.
Reticker-Flynn NE; Zhang W; Belk JA; Basto PA; Escalante NK; Pilarowski GOW; Bejnood A; Martins MM; Kenkel JA; Linde IL; Bagchi S; Yuan R; Chang S; Spitzer MH; Carmi Y; Cheng J; Tolentino LL; Choi O; Wu N; Kong CS; Gentles AJ; Sunwoo JB; Satpathy AT; Plevritis SK; Engleman EG
Cell; 2022 May; 185(11):1924-1942.e23. PubMed ID: 35525247
[TBL] [Abstract][Full Text] [Related]
19. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
Carvalho S; Leijenaar RTH; Troost EGC; van Timmeren JE; Oberije C; van Elmpt W; de Geus-Oei LF; Bussink J; Lambin P
PLoS One; 2018; 13(3):e0192859. PubMed ID: 29494598
[TBL] [Abstract][Full Text] [Related]
20. Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?
Deng HY; Zhou J; Wang RL; Jiang R; Zhu DX; Tang XJ; Zhou Q
Ann Surg Oncol; 2020 Feb; 27(2):472-480. PubMed ID: 31617120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
